Leverage Shares 3x Long Eli Lilly LLY ETP Securities (LON:3LLY)

London · Delayed Price · Currency is GBP · Price in GBX

3,387.00

+126.50 (3.88%)

Last updated: Sep 22, 2026, 4:21 PM GMT

Assets	396.54K
Expense Ratio	0.013%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+127.77%

Volume	611
Open	3,251.79
Previous Close	3,260.50
Day's Range	3,043.00 - 3,387.00
52-Week Low	1,298.00
52-Week High	4,489.00
Beta	n/a
Holdings	2
Inception Date	Sep 16, 2025

About 3LLY

Leverage Shares 3x Long Eli Lilly ETP Securities is a daily leveraged exchange traded product designed to provide three times the daily performance of Eli Lilly and Company shares. Issued by Leverage Shares PLC, this ETP allows professional and sophisticated investors to amplify exposure to the price movements of Eli Lilly, a major player in the global pharmaceutical sector, by tracking the Euronext 3X Long Eli Lilly Index. Structured as a debt security and denominated in USD, the product employs physical replication to achieve its targeted leverage, rather than derivatives, which can contribute to more transparent exposure. Dividends from the underlying stock are capitalized within the product, reinforcing its total return approach. Leverage Shares has designed this ETP for use across several European countries, supporting both trading flexibility and accessibility for those seeking tactical, short-term positioning in the health care industry. By facilitating three times the daily returns—positive or negative—of Eli Lilly's stock, this ETP serves as a focused tool for expressing high conviction views on one of the world’s most influential pharmaceutical companies within modern financial markets.

Asset Class Equity

Category Health Care

Stock Exchange London Stock Exchange

Ticker Symbol 3LLY

Provider Leverage Shares

Index Tracked Euronext 3X Long Eli Lilly Index - Benchmark TR Net

Performance

3LLY had a total return of 127.77% in the past year, including dividends. Since the fund's inception, the average annual return has been 119.49%.

Top Holdings

Name	Symbol	Weight
Eli Lilly and Company	LLY	300.37%
Cash	n/a	-200.37%